Hormone Replacement Therapy: Risks and Benefits
Author(s) -
Laura Gomes Lima,
Najwa Munir Tayfour,
Paula Cristina Oliveira Lemos,
Maryanna Freitas Alves,
Isadora Mota Ferreira,
Eriston Vieira Gomes
Publication year - 2020
Publication title -
integrative journal of medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2658-8218
DOI - 10.15342/ijms.7.242
Subject(s) - climacteric , hormone replacement therapy (female to male) , context (archaeology) , medicine , estrogen , amenorrhea , intensive care medicine , menopause , estrogen replacement therapy , hormone , gynecology , physiology , testosterone (patch) , biology , paleontology , genetics , pregnancy
The climacteric is a physiological period of the female reproductive cycle characterized by a decrease in the levels of sex hormones, mainly estrogen. It consists of several phases, with amenorrhea as the initial clinical manifestation followed by longterm changes, such as vaginal atrophy. In this context, hormone replacement therapy (HRT) aims to improve the symptoms of female reproductive senescence, seeking to provide a comfortable physical and psychological condition during this period. However, as with any drug treatment, HRT has its risks and benefits, and it is up to the medical practitioner, in agreement with the patient, looking for the best therapeutic option, minimizing the risks and consequences resulting from this clinical approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom